HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mi Kwon Selected Research

itacitinib

1/2022Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mi Kwon Research Topics

Disease

18Graft vs Host Disease (Graft-Versus-Host Disease)
05/2024 - 01/2015
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 08/2012
10Neoplasms (Cancer)
01/2023 - 10/2013
10Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 10/2013
8B-Cell Lymphoma (Lymphoma, B Cell)
12/2023 - 01/2021
7Infections
10/2022 - 01/2019
6Leukemia
05/2024 - 09/2014
5Lymphoma (Lymphomas)
12/2023 - 01/2018
4Cytokine Release Syndrome
01/2023 - 10/2020
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2023 - 04/2021
3Neutropenia
06/2023 - 04/2020
3COVID-19
12/2021 - 10/2020
2Bronchiolitis Obliterans Syndrome
04/2024 - 01/2020
2Thrombocytopenia (Thrombopenia)
06/2023 - 01/2022
2Cytopenia
06/2023 - 10/2022
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2023 - 01/2022
2Disease Progression
10/2022 - 01/2021
2Hemorrhagic Cystitis
01/2022 - 01/2013
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2022 - 11/2020
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 09/2018
2Invasive Fungal Infections
10/2021 - 01/2019
2Hematologic Diseases (Blood Diseases)
04/2021 - 01/2019
2Hodgkin Disease (Hodgkin's Disease)
10/2017 - 05/2016
2Residual Neoplasm
09/2014 - 08/2012
1Pathologic Complete Response
05/2024
1cell-associated neurotoxicity
01/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022
1Macrophage Activation Syndrome
01/2022
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2022
1Communicable Diseases (Infectious Diseases)
12/2021
1Fever (Fevers)
04/2021
1Renal Insufficiency (Renal Failure)
11/2020
1Ascites
11/2020
1Hepatomegaly
11/2020
1Hepatorenal Syndrome
11/2020
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2020
1Composite Lymphoma
11/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2020
1Inflammation (Inflammations)
10/2020
1Fusariosis
04/2020
1Breakthrough Infections
04/2020
1AIDS-Related Lymphoma (Lymphoma, AIDS Related)
01/2020
1Aspergillosis
01/2019

Drug/Important Bio-Agent (IBA)

14Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2024 - 09/2018
12Chimeric Antigen ReceptorsIBA
12/2023 - 01/2021
5Biomarkers (Surrogate Marker)IBA
01/2023 - 04/2020
4tisagenlecleucelIBA
01/2023 - 01/2021
2Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
05/2024 - 11/2018
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2023 - 10/2022
2axicabtagene ciloleucelIBA
01/2023 - 04/2021
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 04/2021
2EnzymesIBA
01/2022 - 12/2007
2tocilizumab (atlizumab)FDA Link
04/2021 - 04/2021
1Bendamustine HydrochlorideFDA Link
10/2023
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
06/2023
1Prostaglandins FIBA
06/2023
1Cell-Free Nucleic AcidsIBA
01/2023
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2023
1Antifungal AgentsIBA
10/2022
1Thrombopoietin (c-mpl Ligand)IBA
10/2022
1Azacitidine (5 Azacytidine)FDA Link
01/2022
1Bortezomib (Velcade)FDA Link
01/2022
1itacitinibIBA
01/2022
1carfilzomibIBA
01/2022
1brexucabtagene autoleucelIBA
01/2022
1dimemorfan (AT 17)IBA
10/2021
1ElafinIBA
01/2021
1defibrotideIBA
11/2020
1CreatinineIBA
11/2020
1Alanine Transaminase (SGPT)IBA
11/2020
1Antineoplastic Agents (Antineoplastics)IBA
10/2020
1Antiviral Agents (Antivirals)IBA
10/2020
1Monoclonal AntibodiesIBA
10/2020
1CytokinesIBA
10/2020
1Micafungin (FK463)FDA Link
04/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1SteroidsIBA
01/2020
1Amphotericin B (Amphotericin)FDA LinkGeneric
01/2019
1posaconazoleFDA Link
01/2019
1isavuconazoleIBA
01/2019
1tazobactam drug combination ceftolozaneIBA
01/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2019

Therapy/Procedure

19Hematopoietic Stem Cell Transplantation
04/2024 - 10/2013
17Stem Cell Transplantation
05/2024 - 08/2012
14Therapeutics
12/2023 - 01/2019
13Transplantation
05/2024 - 01/2013
3Cell Transplantation
01/2023 - 10/2021
3Drug Therapy (Chemotherapy)
04/2021 - 10/2020
2Haploidentical Transplantation
05/2024 - 09/2018
2Blood Component Removal (Apheresis)
10/2023 - 01/2023
2Salvage Therapy
10/2022 - 04/2021
2Photopheresis
01/2020 - 08/2019
2Highly Active Antiretroviral Therapy (HAART)
01/2019 - 01/2018
1Medical Day Care (Partial Hospitalization)
01/2022
1Homologous Transplantation
01/2022
1Bone Transplantation (Bone Grafting)
04/2021
1Transjugular Intrahepatic Portasystemic Shunt
11/2020
1Surgical Portasystemic Shunt (Portosystemic Shunt)
11/2020
1Art Therapy
01/2020